The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Cancer risk after renal transplantation in the nordic countries, 1964–1986
Abstract
The theory that cancer may arise under conditions of reduced immune capacity is supported by observations of humans with immune deficiencies such as occur following organ transplants. However, no study on humans has been done in which the reference population was the same as that in which the cancer cases arose and in which there was a sufficiently long period of follow‐up. Information on 5,692 Nordic recipients of renal transplants in 1964–1982 was linked with the national cancer registries (1964‐1986) and population registries. Person‐years at risk were calculated from the date of first transplantation until death or the end of the study period and were multiplied by the appropriate age‐ and calender‐specific incidence rates to obtain the expected numbers of cancers. Standardized incidence ratios (SIR) were calculated after stratification by a number of recorded variables. Altogether, 32,392 person‐years were accrued, and 471 cancers occurred, yielding overall SIR of 4.6 (95% CI, 4.0 to 5.2) for males and 4.5 (95% CI, 4.0 to 5.2) for females. Significant overall 2‐ to 5‐fold excess risks in both sexes were seen for cancers of the colon, larynx, lung and bladder, and in men also for cancers of the prostate and testis. Notably high risks, 10‐fold to 30‐fold above expectation, were associated with cancers of the lip, skin (non‐melanoma), kidney and endocrine glands, also with non‐Hodgkin's lymphoma, and in women also with cancers of the cervix and vulva‐vagina. Among a number of donor and recipient variables studied, including tissue types and compatibility (ABO, HLA, DR), age below 45 years at the time of transplantation was the most important determinant for increased risk at most sites. Kidney transplantation increases the risk of cancer in the short and in the long term, consistent with the theory that an impaired immune system allows carcinogenic factors to act. The tumor risk is small in comparison with the benefits of transplants, but patients should be followed up for signs of cancer. © 1995 Wiley‐Liss. Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE ESTIMATION AND SIGNIFICANCE OF THE LOGARITHM OF A RATIO OF FREQUENCIES
HALDANE, B. J. B. S. (1956) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01285.x · Cited by 1,076
Epidemiologic Analysis with a Programmable Calculator
Rothman, K. J., Boice, H. D., & Austin, H. D. (1982) · American Journal of Epidemiology · Cited by 1,039
INCIDENCE OF SKIN CANCER AFTER RENAL TRANSPLANTATION IN THE NETHERLANDS
HARTEVELT, M. M., BAVINCK, J. N. B., KOOTTE, A. M. M., VERMEER, B. J., & VANDENBROUCKE, J. P. (1990) · Transplantation · doi:10.1097/00007890-199003000-00006 · Cited by 694
RISK OF CANCER IN RENAL-TRANSPLANT RECIPIENTS
Hoover, R. N., & Fraumeni, J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)93256-x · Cited by 596
Kinlen, L. J., Sheil, A. G., Peto, J., & Doll, R. (1979) · BMJ · doi:10.1136/bmj.2.6203.1461 · Cited by 593
Mechanisms of Carcinogenesis in Risk Identification
Vainio, H. (1992) · Medical Entomology and Zoology · Cited by 348
Cancer: causes, occurrence and control
(1991) · Choice Reviews Online · doi:10.5860/choice.29-0340 · Cited by 333
Cohort Study Analysis with a FORTRAN Computer Program
COLEMAN, M., DOUGLAS, A., HERMON, C., & PETO, J. (1986) · International Journal of Epidemiology · doi:10.1093/ije/15.1.134 · Cited by 249
IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS
BURNET, M. (1964) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070310 · Cited by 239
Cutaneous Malignant Neoplasms in Patients With Renal Transplants
Gupta, A. K. (1986) · Archives of Dermatology · doi:10.1001/archderm.122.11.1288 · Cited by 228
Cited by
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Exercise and the immune system: regulation, integration, and adaptation
Pedersen, B. K., & Hoffman-Goetz, L. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1055 · Cited by 1,710
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Spectrum of cancer risk among US solid organ transplant recipients
Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., et al. (2011) · JAMA · doi:10.1001/jama.2011.1592 · Cited by 1,524
Cancer Incidence Before and After Kidney Transplantation
Vajdic, C. M., McDonald, S. P., McCredie, M. R. E., van Leeuwen, M. T., Stewart, J. H., Law, M., Chapman, J. R., Webster, A. C., Kaldor, J. M., & Grulich, A. E. (2006) · JAMA · doi:10.1001/jama.296.23.2823 · Cited by 1,130
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Cancer immunoediting from immune surveillance to immune escape
Kim, R., Emi, M., & Tanabe, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02587.x · Cited by 1,074
Frisch, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1500 · Cited by 885
Jensen, P., Hansen, S., Møller, B., Leivestad, T., Pfeffer, P., Geiran, O., Fauchald, P., & Simonsen, S. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70185-4 · Cited by 871
Association of Cancer With AIDS-Related Immunosuppression in Adults
Frisch, M. (2001) · JAMA · doi:10.1001/jama.285.13.1736 · Cited by 821
Cancer risk following organ transplantation: a nationwide cohort study in Sweden
Adami, J., Gäbel, H., Lindelöf, B., Ekström, K., Rydh, B., Glimelius, B., Ekbom, A., Adami, H.-O., & Granath, F. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601219 · Cited by 692
Cancer epidemiology in the last century and the next decade
Peto, J. (2001) · Nature · doi:10.1038/35077256 · Cited by 681
DeNardo, D. G., & Coussens, L. M. (2007) · Breast Cancer Research · doi:10.1186/bcr1746 · Cited by 677
Immunology and Immunotherapy of Head and Neck Cancer
Ferris, R. L. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.1509 · Cited by 668
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
KASISKE, B. L., VAZQUEZ, M. A., HARMON, W. E., BROWN, R. S., DANOVITCH, G. M., GASTON, R. S., ROTH, D., SCANDLING, J. D., & SINGER, G. G. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11suppl_1s1 · Cited by 634
Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease
Travis, L. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.182 · Cited by 562
Lindelöf, B., Sigurgeirsson, B., Gäbel, H., & Stern, R. S. (2000) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2000.03703.x · Cited by 559
Wolfe, F., & Michaud, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22864 · Cited by 534
Primary Antitumor Immune Response Mediated by CD4+ T Cells
Corthay, A., Skovseth, D. K., Lundin, K. U., Røsjø, E., Omholt, H., Hofgaard, P. O., Haraldsen, G., & Bogen, B. (2005) · Immunity · doi:10.1016/j.immuni.2005.02.003 · Cited by 478
Antonsson, A., Forslund, O., Ekberg, H., Sterner, G., & Hansson, B. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11636-11641.2000 · Cited by 424
Post-Transplant Malignancy: The Role Of Immunosuppression
Penn, I. (2000) · Drug Safety · doi:10.2165/00002018-200023020-00002 · Cited by 414
Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients: A Systematic Review
Gutierrez-Dalmau, A., & Campistol, J. M. (2007) · Drugs · doi:10.2165/00003495-200767080-00006 · Cited by 408
Human papillomaviruses: diversity, infection and host interactions
McBride, A. A. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00617-5 · Cited by 369
Rakhra, K., Bachireddy, P., Zabuawala, T., Zeiser, R., Xu, L., Kopelman, A., Fan, A. C., Yang, Q., Braunstein, L., Crosby, E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.002 · Cited by 339
Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer
Harkins, L., Volk, A. L., Samanta, M., Mikolaenko, I., Britt, W. J., Bland, K. I., & Cobbs, C. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11524-8 · Cited by 346
Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification: Part Two
Cassarino, D. S., DeRienzo, D. P., & Barr, R. J. (2006) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2006.00516.x · Cited by 345
The non-Hodgkin lymphomas: A review of the epidemiologic literature
Alexander, D. D., Mink, P. J., Adami, H.-O., Chang, E. T., Cole, P., Mandel, J. S., & Trichopoulos, D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22719 · Cited by 343
Ménétrier-Caux, C., Ray-Coquard, I., Blay, J.-Y., & Caux, C. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0549-5 · Cited by 339
Control of the Immune Response by Pro-Angiogenic Factors
Voron, T., Marcheteau, E., Pernot, S., Colussi, O., Tartour, E., Taieb, J., & Terme, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00070 · Cited by 325
Oncolytic virus immunotherapy: future prospects for oncology
Raja, J., Ludwig, J. M., Gettinger, S. N., Schalper, K. A., & Kim, H. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0458-z · Cited by 313
Cancer risk in patients on dialysis and after renal transplantation
Birkeland, S., L⊘kkegaard, H., & Storm, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02298-4 · Cited by 296
Self-citationCancers in Renal Transplant Recipients
Penn, I. (2000) · Advances in Renal Replacement Therapy · doi:10.1053/rr.2000.5269 · Cited by 284
Classic Kaposi sarcoma: Epidemiology and risk factors
Iscovich, J., Boffetta, P., Franceschi, S., Azizi, E., & Sarid, R. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<500::aid-cncr3>3.0.co;2-9 · Cited by 280
Does the Immune System Naturally Protect Against Cancer?
Corthay, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00197 · Cited by 261
Increased Risk for Cancer Following Sarcoidosis
ASKLING, J., GRUNEWALD, J., EKLUND, A., HILLERDAL, G., & EKBOM, A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9904045 · Cited by 260
Marcil, I., & Stern, R. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06179-7 · Cited by 258
Malignancy in Renal Transplantation
Morath, C., Mueller, M., Goldschmidt, H., Schwenger, V., Opelz, G., & Zeier, M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000126194.77004.9b · Cited by 229
Immune Response Associated with Nonmelanoma Skin Cancer
Strickland, F. M., & Kripke, M. L. (1997) · Clinics in Plastic Surgery · doi:10.1016/s0094-1298(20)32287-2 · Cited by 31
Metadata
- Authors
- Birkeland, S. A., Storm, H. H., Lamm, L. U., Barlow, L., Blohmé, I., Forsberg, B., Eklund, B., Fjeldborg, O., Friedberg, M., Frödin, L., Glattre, E., Halvorsen, S., Holm, N. V., Jakobsen, A., Jorgensen, H. E., Ladefoged, J., Lindholm, T., Lundgren, G., & Pukkala, E.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1995-01-17
- Volume
- 60
- Issue
- 2
- Pages
- 183-189
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2128692203
- Cited by
- 613
- References
- 17
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.